NASDAQ · CDXS
Codexis, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CDXS: Nov 12, 2026
Codexis, Inc. Common Stock is expected to report earnings on 11/12/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.09. The reported EPS for the same quarter last year was $-0.22.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.09 | $-0.09 | $-0.09 | 2 |
| Dec 2026 | $-0.03 | $-0.01 | $-0.05 | 2 |
| Mar 2027 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Jun 2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Zacks · MarketBeat- RTTNews · Oct 2, 12:13 PM EDTWeekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data(RTTNews) – The week brought a fresh round of developments across the biotech and pharma landscape, with companies advancing new therapies through regulatory milestones, clinical studies, strategic deals and corporate activity. Key updates spanned oncology, rare diseases, cardiov
- RTTNews · Sep 28, 1:25 PM EDTCodexis Partners With SiRNA Drug Developer To Advance Next-Generation RNA Manufacturing(RTTNews) – Codexis, Inc, (CODX) announced an agreement with a pioneering siRNA drug innovator to evaluate its ECO Synthesis Manufacturing Platform.
- The Motley Fool · Aug 18, 7:27 PM EDTCodexis (CDXS) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 14, 12:00 PM EDTCodexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?Codexis (CDXS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- RTTNews · Aug 12, 1:22 AM EDTCodexis Q2 Net Loss Narrows; Reaffirms 2026 Guidance; Plans To Advance ECO GMP Manufacturing Centre(RTTNews) – Codexis, Inc. (CDXS) announced on Tuesday financial results for the second quarter ended June 30, 2026, reflecting a narrower net loss and provided a business update. In addition, the company reaffirmed the full-year 2026 guidance.
- MarketBeat · Aug 11, 6:04 PM EDTCodexis Q2 Earnings Call HighlightsCodexis (NASDAQ:CDXS) reported second-quarter 2026 revenue of $14.9 million, compared with $15.3 million in the prior-year period, as the company highlighted improved performance in its biocatalytic enzyme business and continued development of its ECO Synthesis platform for siRNA
- Zacks · Aug 11, 5:45 PM EDTCodexis (CDXS) Reports Q2 Loss, Tops Revenue EstimatesCodexis (CDXS) delivered earnings and revenue surprises of +23.53% and +17.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 7, 8:05 AM EDTANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Beat EstimatesANI (ANIP) delivered earnings and revenue surprises of +9.95% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 6, 5:20 PM EDTArcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue EstimatesArcturus Therapeutics (ARCT) delivered earnings and revenue surprises of +21.50% and +18.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 5, 9:55 AM EDTAC Immune (ACIU) Beats Q2 Earnings and Revenue EstimatesAC Immune (ACIU) delivered earnings and revenue surprises of +113.64% and +1,812.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Jul 24, 3:31 AM EDTCodexis Prices Public Offering Of 16.67 Mln Shares At $1.50/Shr; Stock Drops 19%(RTTNews) – Codexis, Inc. (CDXS), a provider of enzymatic solutions, announced the pricing of its public offering of 16.67 million shares at a price of $1.50 per share.
- The Motley Fool · May 8, 3:32 PM EDTCodexis (CDXS) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Codexis, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.